Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delavirdine mesylate + NRTIs in HIV-infected children
NCT00002210Phase 2Completed
- Sponsor
- Pfizer
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of delavirdine in human immunodeficiency virus infection (HIV), sponsored by Pfizer. Primary endpoints: Safety and Tolerance and Pharmacokinetics. Status: completed.
02
Drugs
delavirdine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002210.